Human Antithrombin III Deficient Citrate Plasma

<strong>Human Antithrombin III Deficient Citrate Plasma </strong>_x000D_ <strong>Catalog number:</strong> B2014931_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Lyophilized_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20° C_x000D_ <strong>Keywords:</strong> Antithrombin-III, ATIII, Serpin C1, AT3_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Hoffman DL. Purification and large-scale preparation of antithrombin III Am J Med. 1989 Sep 11;87(3B):23S-26S._x000D_ 2: Miljić P, Rolović Z, Elezović I, Antunović P, Stanojević M, Colović M. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis] Srp Arh Celok Lek. 1999 Jan-Feb;127(1-2):21-7._x000D_ 3: de Boer HC, de Groot PG, Bouma BN, Preissner KT. Ternary vitronectin-thrombin-antithrombin III complexes in human plasma. Detection and mode of association J Biol Chem. 1993 Jan 15;268(2):1279-83._x000D_ 4: McRoyan DK, McRoyan CJ, Sauter KL, Liu PI, Daniel SJ. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components Ann Clin Lab Sci. 1985 Mar-Apr;15(2):165-70._x000D_ 5: Lopez E, Peng Z, Kozar RA, Cao Y, Ko TC, Wade CE, Cardenas JC. Antithrombin III Contributes to the Protective Effects of Fresh Frozen Plasma Following Hemorrhagic Shock by Preventing Syndecan-1 Shedding and Endothelial Barrier Disruption Shock. 2020 Feb;53(2):156-163._x000D_ 6: Pirisi M, Fabris C, Ceriello A, Soardo G, Giacomello R, Toniutto P, Vitulli D, Gonano F, Bartoli E. Deficient antithrombin III activity and enhanced fibrinolysis in patients with liver disease: evidence against a cause-effect relationship Acta Gastroenterol Belg. 1995 Mar-Apr;58(2):230-7._x000D_ 7: Cucuianu M, Blaga S, Pop S, Olinic D, Olinic N, Colhon D, Cristea A. Antithrombin III deficiency Rom J Intern Med. 1994 Apr-Jun;32(2):119-27._x000D_ 8: Yamauchi T, Asakura E, Amatsuji Y, Uno S, Furuta R, Tujikawa M, Tanabe T. Production of human antithrombin-III in a serum-free culture of CHO cells Biosci Biotechnol Biochem. 1992 Apr;56(4):600-4._x000D_ 9: de la Morena-Barrio M, Sandoval E, Llamas P, Wypasek E, Toderici M, Navarro-Fernández J, Rodríguez-Alen A, Revilla N, López-Gálvez R, Miñano A, Padilla J, de la Morena-Barrio B, Cuesta J, Corral J, Vicente V. High levels of latent antithrombin in plasma from patients with antithrombin deficiency Thromb Haemost. 2017 May 3;117(5):880-888._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/8186352">10: Schmidt BK. Antithrombin III deficiency in neonatal respiratory distress syndrome Blood Coagul Fibrinolysis. 1994 Jan;5 Suppl 1:S13-7; discussion S59-64. </a>_x000D_ _x000D_ <strong>Products Related to Human Antithrombin III Deficient Citrate Plasma can be found at</strong> <a href="https://moleculardepot.com/product-category/Biofluids/"> Biofluids</a>